» Articles » PMID: 33997503

MoS-based Nanocomposites for Cancer Diagnosis and Therapy

Overview
Journal Bioact Mater
Date 2021 May 17
PMID 33997503
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Molybdenum is a trace dietary element necessary for the survival of humans. Some molybdenum-bearing enzymes are involved in key metabolic activities in the human body (such as xanthine oxidase, aldehyde oxidase and sulfite oxidase). Many molybdenum-based compounds have been widely used in biomedical research. Especially, MoS-nanomaterials have attracted more attention in cancer diagnosis and treatment recently because of their unique physical and chemical properties. MoS can adsorb various biomolecules and drug molecules via covalent or non-covalent interactions because it is easy to modify and possess a high specific surface area, improving its tumor targeting and colloidal stability, as well as accuracy and sensitivity for detecting specific biomarkers. At the same time, in the near-infrared (NIR) window, MoS has excellent optical absorption and prominent photothermal conversion efficiency, which can achieve NIR-based phototherapy and NIR-responsive controlled drug-release. Significantly, the modified MoS-nanocomposite can specifically respond to the tumor microenvironment, leading to drug accumulation in the tumor site increased, reducing its side effects on non-cancerous tissues, and improved therapeutic effect. In this review, we introduced the latest developments of MoS-nanocomposites in cancer diagnosis and therapy, mainly focusing on biosensors, bioimaging, chemotherapy, phototherapy, microwave hyperthermia, and combination therapy. Furthermore, we also discuss the current challenges and prospects of MoS-nanocomposites in cancer treatment.

Citing Articles

Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy.

Pei D, Zhang D, Guo Y, Chang H, Cui H Int J Mol Sci. 2025; 26(2).

PMID: 39859408 PMC: 11766336. DOI: 10.3390/ijms26020694.


Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy.

Li H, Gong Y, Yan P, Xu Y, Qin G, Wen W Front Immunol. 2024; 15:1453753.

PMID: 39676875 PMC: 11638222. DOI: 10.3389/fimmu.2024.1453753.


A comprehensive genome-based analysis identifies the anti-cancerous role of the anoikis-related gene ADH1A in modulating the pathogenesis of breast cancer.

Chen C, Guo S, Chai W, Yang J, Yang Y, Chen G Mol Genet Genomics. 2024; 299(1):108.

PMID: 39531174 DOI: 10.1007/s00438-024-02200-y.


Alleviating rheumatoid arthritis with a photo-pharmacotherapeutic glycan-integrated nanogel complex for advanced percutaneous delivery.

Weng P, Lu H, Rethi L, Liu C, Wong C, Rethi L J Nanobiotechnology. 2024; 22(1):646.

PMID: 39428483 PMC: 11492540. DOI: 10.1186/s12951-024-02877-8.


Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.

Tang M, Rong Y, Li X, Pan H, Tao P, Wu Z BMC Cancer. 2024; 24(1):1163.

PMID: 39300389 PMC: 11411761. DOI: 10.1186/s12885-024-12830-5.


References
1.
Peng G, Li X, Cui F, Qiu Q, Chen X, Huang H . Aflatoxin B1 Electrochemical Aptasensor Based on Tetrahedral DNA Nanostructures Functionalized Three Dimensionally Ordered Macroporous MoS-AuNPs Film. ACS Appl Mater Interfaces. 2018; 10(21):17551-17559. DOI: 10.1021/acsami.8b01693. View

2.
Park C, Lee S, Pornnoppadol G, Nam Y, Kim S, Kim B . Microcapsules Containing pH-Responsive, Fluorescent Polymer-Integrated MoS: An Effective Platform for in Situ pH Sensing and Photothermal Heating. ACS Appl Mater Interfaces. 2018; 10(10):9023-9031. DOI: 10.1021/acsami.7b19468. View

3.
Zhao W, Li A, Zhang A, Zheng Y, Liu J . Recent Advances in Functional-Polymer-Decorated Transition-Metal Nanomaterials for Bioimaging and Cancer Therapy. ChemMedChem. 2018; 13(20):2134-2149. DOI: 10.1002/cmdc.201800462. View

4.
Wang K, Chen Q, Xue W, Li S, Liu Z . Combined Chemo-photothermal Antitumor Therapy Using Molybdenum Disulfide Modified with Hyperbranched Polyglycidyl. ACS Biomater Sci Eng. 2021; 3(10):2325-2335. DOI: 10.1021/acsbiomaterials.7b00499. View

5.
Buck C, Lowy D . Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease. J Clin Oncol. 2011; 29(12):1506-8. PMC: 6294996. DOI: 10.1200/JCO.2010.34.0745. View